Clinical Trial

Evaluation of Bone Regeneration After Apical Surgery Using Advanced Platelet-rich Fibrin: Utilization of Ultrasound for the Assessment of Periapical Lesions

Study acronym: EBRAAPUU
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The study examines the impact of advanced platelet-rich fibrin (A-PRF) on bone regeneration in apical surgery compared to standard methods. It highlights the effectiveness of ultrasound as a diagnostic tool for assessing periapical lesions. Eligible participants were adults with specific periapical lesions following root canal treatment failures. Exclusions included patients outside specific criteria, like those with advanced periodontal disease or undergoing orthodontic treatment. Participants were randomized into two groups: one receiving A-PRF to enhance bone regeneration and a control group without it. Both groups underwent apical surgery under magnification, with different postoperative protocols. The study involved radiological and ultrasonographic evaluations of lesion size and bone healing at baseline, 6 months, and 12 months, alongside blood analyses for Vitamin D and cholesterol level to assess their potential impact on healing.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-13.
Trial Details
NCT Number NCT06734962
Lead Sponsor Riga Stradins University
Conditions Periapical Lesions
Enrollment 44 participants
Start Date 2021-09-12
Primary Completion 2022-09-30 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2024-12-18